Advertisement
MCP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/mcp.M100029-MCP200 on January 24, 2002.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M100029-MCP200v1
1/3/197    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Glossary
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Le Naour, F.
Right arrow Articles by Beretta, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Le Naour, F.
Right arrow Articles by Beretta, L.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Molecular & Cellular Proteomics 1:197-203, 2002.
© 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

Research

A Distinct Repertoire of Autoantibodies in Hepatocellular Carcinoma Identified by Proteomic Analysis*

François Le Naour{ddagger},§, Franck Brichory, David E. Misek, Christian Bréchot||, Samir M. Hanash and Laura Beretta{ddagger},**

{ddagger} Departments of Microbiology and Immunology
Pediatrics, University of Michigan, Ann Arbor, Michigan 48109-0666
|| INSERM U.370, Necker Hospital, 75015 Paris, France

Chronic infections with hepatitis B (HBV) and hepatitis C (HCV) viruses are major risk factors for hepatocellular carcinoma (HCC). We have utilized a proteomic approach to determine whether a distinct repertoire of autoantibodies can be identified in HCC. Sera from 37 patients with HCC and 31 subjects chronically infected with HBV or HCV without HCC were investigated. Sera from 116 patients with other cancers, three patients with systemic lupus erythematosus, and 24 healthy subjects were utilized as controls. We report the identification of eight proteins, for each of which autoantibodies were detected in sera from more than 10% of patients with HCC but not in sera from healthy individuals (p < 0.05). Autoantibodies to four of these proteins were detected at a comparable frequency in sera from patients with chronic hepatitis. The other four proteins, which consisted of calreticulin isoforms, cytokeratin 8, nucleoside diphosphate kinase A, and F1-ATP synthase ß-subunit, induced autoantibodies among patients with HCC, independently of their HBV/HCV status. Calreticulin, and a novel truncated form of calreticulin (Crt32) we have identified, most commonly elicited autoantibodies among patients with HCC (27%). We conclude that a distinct repertoire of autoantibodies is associated with HCC that may have utility in early diagnosis of HCC among high risk subjects with chronic hepatitis.

** To whom correspondence should be addressed: Dept. of Microbiology and Immunology, University of Michigan Medical School, 1150 W. Medical Ctr. Dr., MSRBI-1510, Ann Arbor, MI 48109-0666. Tel.: 734-615-5964; Fax: 734-615-6150; E-mail: berettal{at}umich.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
S. R. Pereira-Faca, R. Kuick, E. Puravs, Q. Zhang, A. L. Krasnoselsky, D. Phanstiel, J. Qiu, D. E. Misek, R. Hinderer, M. Tammemagi, et al.
Identification of 14-3-3{theta} as an Antigen that Induces a Humoral Response in Lung Cancer
Cancer Res., December 15, 2007; 67(24): 12000 - 12006.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Moenner, O. Pluquet, M. Bouchecareilh, and E. Chevet
Integrated Endoplasmic Reticulum Stress Responses in Cancer
Cancer Res., November 15, 2007; 67(22): 10631 - 10634.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
W. Sun, B. Xing, Y. Sun, X. Du, M. Lu, C. Hao, Z. Lu, W. Mi, S. Wu, H. Wei, et al.
Proteome Analysis of Hepatocellular Carcinoma by Two-dimensional Difference Gel Electrophoresis: Novel Protein Markers in Hepatocellular Carcinoma Tissues
Mol. Cell. Proteomics, October 1, 2007; 6(10): 1798 - 1808.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Q. Luo, L. Siconolfi-Baez, P. Annamaneni, M. T. Bielawski, P. M. Novikoff, and R. H. Angeletti
Altered protein expression at early-stage rat hepatic neoplasia
Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1272 - G1282.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
A. Pitarch, A. Jimenez, C. Nombela, and C. Gil
Decoding Serological Response to Candida Cell Wall Immunome into Novel Diagnostic, Prognostic, and Therapeutic Candidates for Systemic Candidiasis by Proteomic and Bioinformatic Analyses
Mol. Cell. Proteomics, January 1, 2006; 5(1): 79 - 96.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S.-H. Hong, D. E. Misek, H. Wang, E. Puravs, T. J. Giordano, J. K. Greenson, D. E. Brenner, D. M. Simeone, C. D. Logsdon, and S. M. Hanash
An Autoantibody-Mediated Immune Response to Calreticulin Isoforms in Pancreatic Cancer
Cancer Res., August 1, 2004; 64(15): 5504 - 5510.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement